Financials
- Market Capitalization 2.48 B
- Employee 34
- Founded 2011
- CEO N/A
- Website www.trevitherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG003QGQRB9
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1847 | SLS SELLAS Life Sciences Group, Inc. - Common Stock | 13.05 USD | -2.54% | +2.51% | +71.71% | +579.69% | 2.43 B USD | ||
| 1849 | IMNM Immunome, Inc. - Common Stock | 22.42 USD | -0.75% | -6.74% | +24.35% | +161.61% | 2.54 B USD | ||
| 1875 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 9.45 USD | -2.98% | -11.27% | +3.96% | +8.00% | 2.40 B USD | ||
| 1878 | NRIX Nurix Therapeutics, Inc. - Common stock | 23.47 USD | +2.13% | -0.30% | +38.63% | +109.37% | 2.44 B USD |